6 ms·
On the other hand, we're talking about a drug that selectively turns off blood flow. That it affects fat cells was only visible because subcutaneous fat is rath
by jacques_chester 15y ago
On the other hand, we're talking about a drug that selectively turns off blood flow. That it affects fat cells was only visible because subcutaneous fat is rather obvious.
But what other cells did it affect? It's not well known yet. For all we know it's stomping on some neurons, or diddling with kidneys, or weakening the left ventricle of monkey hearts. It's too soon to get excited.
- SoftwareMaven 15y agoThere is a lot of fat in the brain. I realize it was targeting adipose fat, but that is still disconcerting until proven otherwise.
- gte910h 15y agoThe blood brain barrier stops many things, I think they'll just test if this does. More troubling is fat in myelin on nerves in the body (It has fat as one of it's components, and loss of it is bad).
- dantheman0207 15y agoThey mention in the article that it had a dose-dependent effect on renal function that was both predictable and reversible. You're definitely correct, in that I wouldn't trust any fat-loss mechanism that works through accelerating apoptosis without extensive human research. However, it's effect on various cells is understood, as it is determined by the type of protein evident on the cell surface. Fat cells are understood(under the vascular mapping prepared by the lab in question) to have this in far greater numbers than any other cell type.